Europe Intrauterine Devices Market

Europe Intrauterine Contraceptive Devices Market Size (2022 to 2027)

The size of the Europe Intrauterine Contraceptive Devices (IUD’S) Market was worth USD 371.20 million in 2022. This figure is estimated to reach USD 473.75 million by the end of 2027, with a growing potential of 5.00% during the forecast period.

Technological advancements, growing demand and usage of contraceptive devices, and new product launches by the market participants are majorly driving the market growth. The latest and advanced intrauterine devices that provide a low risk of ectopic pregnancy are positive signs of market growth. The number of hospital visits with gynecological disorders for women is significantly increasing in Europe, which is further expected to add fuel to the market growth.

Side-effects associated with these devices are expected to restrain the market growth to a small extent. Lack of awareness among the people in the usage of these devices and the high cost of the tools are significant challenges.

This research report has been segmented and sub-segmented the Europe Intrauterine Contraceptive Devices Market into the following categories:

• By Product: Hormonal and Copper Luds
• By End User: Hospitals, Gynecology Clinics, Community Healthcare and Others
• By Country: United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, and Rest of Europe

Regional Analysis:

Europe is the second-largest region, followed by North America in leading the global ICD market due to the technological advancements and increased usage of these devices. 

Germany is expected to lead the European intrauterine contraceptive devices market between 2020 and 2025. In Germany, the government had taken many initiatives and processed some proposals in the recent past with the other organizations, which is significantly increased the market growth.  

Following Germany, the UK market is expected to stand 2nd in accounting for the leading shares in the European market during the forecast period. The introduction of new drugs, medical devices, growth in the number of people opting to avoid pregnancy, and various government initiatives to support the United Kingdom market. The utilization of these devices in the United Kingdom is higher than the entire usage of the European region. 

The Italian market is expected to look like a lucrative region for these devices due to the high number of unplanned pregnancies and the complications relevant to them, and the increasing incidence rate of sexually transmitted diseases. 

Some of the promising companies operating in the Europe Intrauterine Contraceptive Devices Market are Agile Therapeutics, Actavis PLC, ANI Pharmaceuticals Inc., Bayer, Teva Pharmaceutical, Besins HealthCare, Brecuro Medical, Effik International, Eurogine, HLL Lifecare, HRA Pharma, Lupin Pharmaceuticals, Ltd, Okamoto Industries, Inc., and Pfizer.